Newron Pharmaceuticals SpA Financial Overview
Newron Pharmaceuticals SpA's market cap is currently CHF456.11M. The company's EPS TTM is CHF0; its P/E ratio is 19.75; Newron Pharmaceuticals SpA is scheduled to report earnings on September 16, 2025, and the estimated EPS forecast is CHF-0.07. See an overview of income statement, balance sheet, and cash flow financials.
